Northern Trust Corp Bristol Myers Squibb CO Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northern Trust Corp holds 23,002,360 shares of BMY stock, worth $955 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

23,002,360

Previous 24,008,318 4.19%

Holding current value

$955 Million

Previous $1.23 Billion 1.26%

% of portfolio

0.22%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $48.3 Million - $54.7 Million	-1,005,958 Reduced 4.19%	23,002,360 $1.25 Billion
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $62.3 Million - $74.3 Million	-1,284,393 Reduced 5.08%	24,008,318 $1.23 Billion
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $80.7 Million - $90.2 Million	1,394,158 Added 5.83%	25,292,711 $1.47 Billion
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $49.7 Million - $55.2 Million	-780,669 Reduced 3.16%	23,898,553 $1.53 Billion
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $7.33 Million - $8.31 Million	-111,541 Reduced 0.45%	24,679,222 $1.71 Billion

Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $313,569 - $371,311	-4,579 Reduced 0.02%	24,790,763 $1.78 Billion
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $31,890 - $18.8 Million	245,312 Added 1.0%	24,795,342 $1.76 Billion
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $33.6 Million - $37.1 Million	463,344 Added 1.92%	24,550,030 $1.89 Billion
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $27.5 Million - $33 Million	-447,222 Reduced 1.82%	24,086,686 $1.76 Billion
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $24.6 Million - $28.7 Million	-459,260 Reduced 1.84%	24,533,908 $1.53 Billion
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $122 Million - $143 Million	-2,069,677 Reduced 7.65%	24,993,168 $1.48 Billion
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $50.7 Million - $55.2 Million	-818,570 Reduced 2.94%	27,062,845 $1.81 Billion
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $32.1 Million - $36.1 Million	-540,596 Reduced 1.9%	27,881,415 $1.76 Billion
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $36.5 Million - $41.3 Million	-631,360 Reduced 2.17%	28,422,011 $1.76 Billion
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $54.5 Million - $60.4 Million	-948,647 Reduced 3.16%	29,053,371 $1.75 Billion
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $48.3 Million - $56.5 Million	-881,724 Reduced 2.85%	30,002,018 $1.76 Billion
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $19.6 Million - $28.5 Million	-422,644 Reduced 1.35%	30,883,742 $1.72 Billion
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $370 Million - $483 Million	7,523,242 Added 31.63%	31,306,386 $2.01 Billion
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $51.3 Million - $60.9 Million	1,200,199 Added 5.31%	23,783,144 $1.21 Billion
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $1.96 Million - $2.17 Million	43,908 Added 0.19%	22,582,945 $1.02 Billion
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $1.71 Million - $2.04 Million	-37,847 Reduced 0.17%	22,539,037 $1.08 Billion
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $46.6 Million - $60.4 Million	954,877 Added 4.42%	22,576,884 $1.17 Billion
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $23.6 Million - $26.6 Million	-427,054 Reduced 1.94%	21,622,007 $1.34 Billion
Q2 2018 Sep 18, 2018	SELL	$50.53 - $62.98 $5.36 Million - $6.68 Million	-106,046 Reduced 0.48%	22,049,061 $1.22 Billion
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $37.4 Million - $46.6 Million	-740,132 Reduced 3.23%	22,155,107 $1.23 Billion
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $78.9 Million - $90.8 Million	-1,316,122 Reduced 5.44%	22,895,239 $1.45 Billion
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $24.8 Million - $27.1 Million	-414,028 Reduced 1.68%	24,211,361 $1.48 Billion
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $1.36 Billion - $1.57 Billion	24,625,389	24,625,389 $1.57 Billion

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Bristol Myers Squibb CO Transaction History